Eprisan SR Capsule contains Eperisone 150 mg, a centrally acting muscle relaxant indicated for the relief of muscle spasticity and associated pain in various neuromuscular disorders. Eperisone exerts its therapeutic effect by inhibiting spinal reflexes and improving muscle blood flow, thereby reducing muscle stiffness and enhancing mobility. It is commonly prescribed for conditions such as cervical spondylosis, lumbar spondylosis, muscle spasm due to trauma or neurological diseases, and other musculoskeletal disorders characterized by increased muscle tone. The sustained-release formulation of Eprisan SR ensures prolonged therapeutic action, allowing for convenient dosing and improved patient compliance. Eperisone is generally well tolerated; however, adverse effects may include dizziness, headache, gastrointestinal disturbances, and rarely, hypersensitivity reactions. Caution is advised in patients with hepatic or renal impairment, and it should be used under medical supervision, particularly in pregnant or lactating women. Eprisan SR Capsule should be taken as directed by a healthcare professional, typically with or after meals to minimize gastrointestinal discomfort. It is contraindicated in patients with known hypersensitivity to Eperisone or any of the capsule excipients. Regular monitoring and adherence to prescribed dosage are essential to achieve optimal therapeutic outcomes.